These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 32713129)

  • 1. The one-stage assay or chromogenic assay to monitor baseline factor VIII levels and desmopressin effect in non-severe haemophilia A: Superiority or non-inferiority?
    Schütte LM; Hodes LS; van Moort I; Stoof SCM; Leebeek FWG; Cnossen MH; de Maat MPM; Kruip MJHA
    Haemophilia; 2020 Sep; 26(5):916-922. PubMed ID: 32713129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desmopressin in haemophilia: The need for a standardised clinical response and individualised test regimen.
    Stoof SCM; Schütte LM; Leebeek FWG; Cnossen MH; Kruip MJHA
    Haemophilia; 2017 Nov; 23(6):861-867. PubMed ID: 28636264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic Modelling to Predict FVIII:C Response to Desmopressin and Its Reproducibility in Nonsevere Haemophilia A Patients.
    Schütte LM; van Hest RM; Stoof SCM; Leebeek FWG; Cnossen MH; Kruip MJHA; Mathôt RAA
    Thromb Haemost; 2018 Apr; 118(4):621-629. PubMed ID: 29458233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desmopressin treatment combined with clotting factor VIII concentrates in patients with non-severe haemophilia A: protocol for a multicentre single-armed trial, the DAVID study.
    Schütte LM; Cnossen MH; van Hest RM; Driessens MHE; Fijnvandraat K; Polinder S; Beckers EAM; Coppens M; Eikenboom J; Laros-van Gorkom BAP; Meijer K; Nieuwenhuizen L; Mauser-Bunschoten EP; Leebeek FWG; Mathôt RAA; Kruip MJHA
    BMJ Open; 2019 Apr; 9(4):e022719. PubMed ID: 31015264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response to desmopressin is strongly dependent on F8 gene mutation type in mild and moderate haemophilia A.
    Stoof SC; Sanders YV; Petrij F; Cnossen MH; de Maat MP; Leebeek FW; Kruip MJ
    Thromb Haemost; 2013 Mar; 109(3):440-9. PubMed ID: 23348756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peri-operative desmopressin combined with pharmacokinetic-guided factor VIII concentrate in non-severe haemophilia A patients.
    Romano LGR; Schütte LM; van Hest RM; Meijer K; Laros-van Gorkom BAP; Nieuwenhuizen L; Eikenboom J; Heubel-Moenen FCJI; Uitslager N; Coppens M; Fijnvandraat K; Driessens MHE; Polinder S; Cnossen MH; Leebeek FWG; Mathôt RAA; Kruip MJHA;
    Haemophilia; 2024 Mar; 30(2):355-366. PubMed ID: 38343113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and management challenges in patients with mild haemophilia A and discrepant FVIII measurements.
    Trossaert M; Lienhart A; Nougier C; Fretigny M; Sigaud M; Meunier S; Fouassier M; Ternisien C; Negrier C; Dargaud Y
    Haemophilia; 2014 Jul; 20(4):550-8. PubMed ID: 24517184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desmopressin in non-severe haemophilia A: Test-response and clinical outcomes in a single Canadian centre review.
    Hews-Girard J; Rydz N; Lee A; Goodyear MD; Poon MC
    Haemophilia; 2018 Sep; 24(5):720-725. PubMed ID: 30004154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromogenic assay for BAY 81-8973 potency assignment has no impact on clinical outcome or monitoring in patient samples.
    Kitchen S; Katterle Y; Beckmann H; Maas Enriquez M
    J Thromb Haemost; 2016 Jun; 14(6):1192-9. PubMed ID: 27002680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemophilia A mutations in patients with non-severe phenotype associated with a discrepancy between one-stage and chromogenic factor VIII activity assays.
    Pavlova A; Delev D; Pezeshkpoor B; Müller J; Oldenburg J
    Thromb Haemost; 2014 May; 111(5):851-61. PubMed ID: 24452774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of three automated chromogenic FVIII kits for the diagnosis of mild discrepant haemophilia A.
    Rodgers SE; Duncan EM; Sobieraj-Teague M; Lloyd JV
    Int J Lab Hematol; 2009 Apr; 31(2):180-8. PubMed ID: 18190586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discrepancies between the one-stage clotting assay and the chromogenic assay in haemophilia B.
    Kihlberg K; Strandberg K; Rosén S; Ljung R; Astermark J
    Haemophilia; 2017 Jul; 23(4):620-627. PubMed ID: 28440032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and phenotypic determinants of the response to desmopressin in adult patients with mild hemophilia A.
    Castaman G; Mancuso ME; Giacomelli SH; Tosetto A; Santagostino E; Mannucci PM; Rodeghiero F
    J Thromb Haemost; 2009 Nov; 7(11):1824-31. PubMed ID: 19719828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico and in vitro evaluation of the impact of mutations in non-severe haemophilia A patients on assay discrepancies.
    Pezeshkpoor B; Gazorpak M; Berkemeier AC; Singer H; Pavlova A; Biswas A; Oldenburg J
    Ann Hematol; 2019 Aug; 98(8):1855-1865. PubMed ID: 30997536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discrepancy between the results of one-stage and chromogenic factor VIII: C assays in patients with mild/moderate hemophilia A.
    Vosough F; Ahmadinejad M; Toogeh G; Karimi K; Homayoun S; Managhchi MR; Arabkhazaeli A
    Blood Coagul Fibrinolysis; 2020 Dec; 31(8):530-535. PubMed ID: 33141777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombin generation in haemophilia A patients with mutations causing factor VIII assay discrepancy.
    Gilmore R; Harmon S; Gannon C; Byrne M; O'Donnell JS; Jenkins PV
    Haemophilia; 2010 Jul; 16(4):671-4. PubMed ID: 20148980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-stage vs. chromogenic assays in haemophilia A.
    Potgieter JJ; Damgaard M; Hillarp A
    Eur J Haematol; 2015 Feb; 94 Suppl 77():38-44. PubMed ID: 25560793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro kinetics of factor VIII activity in patients with mild haemophilia A and a discrepancy between one-stage and two-stage factor VIII assay results.
    Rodgers SE; Duncan EM; Barbulescu DM; Quinn DM; Lloyd JV
    Br J Haematol; 2007 Jan; 136(1):138-45. PubMed ID: 17222201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DDAVP challenge tests in boys with mild/moderate haemophilia A.
    Revel-Vilk S; Blanchette VS; Sparling C; Stain AM; Carcao MD
    Br J Haematol; 2002 Jun; 117(4):947-51. PubMed ID: 12060135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of an automated chromogenic assay for Factor VIII clotting activity measurement in patients affected by haemophilia A.
    Novembrino C; Boscolo Anzoletti M; Mancuso ME; Shinohara S; Peyvandi F
    Haemophilia; 2019 May; 25(3):521-526. PubMed ID: 31044485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.